News

October 10, 2019
Agreement includes partnership to produce the world-renowned Leipzig Interventional Course (LINC), and further establishes the company’s position as a leading global provider of healthcare events
October 8, 2019
Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms.
October 7, 2019
EP Map System, GmbH, a Herdecke, Germany-based company that has developed a suite of technologies focused on electrophysiology (EP) procedures, announced the closing of a $25 million Series A financing round led by Ajax Health.
October 3, 2019
Preventice Solutions announced it received a tender from the UK Biobank to provide the BodyGuardian® MINI remote cardiac monitor for a cardiovascular monitoring study involving up to 30,000 participants.
October 3, 2019
Milestone Pharmaceuticals Inc., a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, announced that the first patient has been enrolled in the Phas
September 30, 2019
Orchestra BioMed™, Inc., (Orchestra BioMed), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, announced that late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac Neuromodulation Therapy™ (CNT™) demonstrated statistically significant and cli
September 27, 2019
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.